What AxLR does

AxLR (legal name: AxLR, SATT Occitanie Méditerranée) is a French technology transfer acceleration organization headquartered in Montpellier, founded in 2012 and operating as a private SAS (Société par actions simplifiée). Designated as the regional SATT (Société d'Accélération de Transfert de Technologie) for Occitanie Méditerranée, it bridges public research laboratories and industry by funding the maturation of early-stage innovations, protecting intellectual property, licensing technologies, and creating deeptech startups. Its scope spans five scientific domains: Health & Biotechnology, Agronomy/Ecology/Environment, Mathematics/Computing/Physics, Chemistry/Materials, and Human/Social Sciences.

The organization operates a multi-product platform built around three core offerings: (1) the Tech-365 digital marketplace, developed with the national Réseau SATT, providing access to ~1,000 public research innovations and serving ~300 corporate subscribers; (2) the TTM Factory startup incubator, hosting spin-outs such as Graft Smart and E-ETHYLENE; and (3) the Booster Innovation Montpellier (BIM) call-for-projects program for early-stage researcher-led projects. Underlying these is a maturation investment engine that deploys patient capital — ranging from €179K (Leishmania vaccine) and €317K (llama nanobodies, Nature publication July 2025) up to €670K (E-ETHYLENE) and >€1M (Graft Smart's Flow Graft organ transplantation platform) — across pre-maturation, maturation, and licensing stages. In 2018 alone, AxLR supported 22 projects, concluded 15 technology transfer contracts, and generated €1.5M in transfer revenue (+161% YoY).

AxLR's business model combines three revenue streams: technology licensing royalties, paid services to enterprises seeking access to public research innovations, and returns from maturation investments via equity stakes, licensing fees, and royalties. Primary funding flows through periodic French State tranches (€22M for 2019-2021) supplemented by shareholder contributions from Région Occitanie, Montpellier Méditerranée Métropole, and Bpifrance. As the regional hub within the 13-SATT national network, AxLR benefits from distribution reach across France and maintains deep institutional ties to Université de Montpellier, CNRS, INSERM, IRD, and regional hospitals, with operational standardization certified under ISO 9001:2015 since September 2020.

Name

AxLR

Legal name

AxLR, SATT Occitanie Méditerranée

Website

https://axlr.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

AxLR is a French technology transfer acceleration organization (SATT) based in Montpellier that bridges public research laboratories and industry in the Occitanie Méditerranée region, funding innovation maturation, protecting IP, licensing technologies, and creating deeptech startups across five scientific domains.

Ownership category

akta.pro rank

Headquarters

HQ city

Montpellier

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Technology licensing: AxLR licenses technologies developed from public research to companies, generating transfer revenues. In 2018, transfer operations generated €1.5M in revenue (161% growth vs 2017).
2. Services to enterprises: Provides paid services to companies seeking access to public research innovations, technology scouting, and innovation consulting.
3. Maturation investment returns: AxLR invests in project maturation (€6.5M invested in new maturation projects in 2018 alone) and recovers value through equity stakes, licensing fees, and royalties when technologies reach commercialization.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

AxLR is a French SATT (Société d'Accélération de Transfert de Technologie) that funds the maturation of inventions from public research laboratories and transfers them to industry through licensing, co-development partnerships, and startup creation. It manages a portfolio of technologies across five domains (Health & Biotechnology, Agronomy/Environment, Mathematics/Computing/Physics, Chemistry/Materials, Human/Social Sciences), provides IP protection and business development support, and operates the TTM Factory startup incubator along with the Booster Innovation Montpellier (BIM) program.

Product overview

AxLR (SATT Occitanie Méditerranée) is a technology transfer acceleration company that connects public research with industry. The organization operates as a unified service platform offering technology transfer facilitation, startup incubation through TTM Factory, maturation funding programs, and access to the Tech-365 innovation marketplace. AxLR supports researchers and companies across five technology domains: Health & Biotechnology, Agronomy & Environment, Mathematics & Computer Science, Chemistry & Materials, and Human & Social Sciences. Their core offering is helping transform academic research into commercially viable products and services.

Differentiator

Problem solved

Functional benefit

Products and services

• Technology Transfer Services AxLR facilitates the transfer of technologies from public research laboratories to companies, providing investment, intellectual property protection, and commercialization support across five technology domains (Health & Biotechnology, Agronomy/Environment, Mathematics/Computing/Physics, Chemistry/Materials, Human/Social Sciences).
• TTM Factory Startup Incubator

Quantifiable outcome

• 22 projects supported and €6.5M invested in new maturation projects in 2018
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

28 partnerships are on record, tiered core, major and minor.

• CTIBIOTECHcoreStrategic or Co-development PartnerCTIBIOTECH collaborated with SATT AxLR and CILCARE on a strategic agreement to develop 3D bioprinted inner ear organoids from human induced pluripotent stem cells, aimed at improving pharmacological screening for hearing disorders and reducing animal testing.
• CILCAREcoreStrategic or Co-development PartnerCILCARE partnered with SATT AxLR and CTIBIOTECH to develop 3D bioprinted inner ear organoids for hearing disorder research and pharmacological screening, focusing on mass production and animal testing reduction.
• Réseau SATTcoreStrategic or Co-development PartnerThe national SATT network connects all French SATT organizations (13 full SATT + 5 SATTe). AxLR participates in joint initiatives including the Tech-365 platform (serving ~300 subscribers), Tech-365 Meetings events (200+ experts, 1,000+ innovations), and the SATT network's technology scouting offer.
• Université de MontpelliercoreStrategic or Co-development PartnerAxLR's primary research partner and shareholder. The university provides the research base from which technologies are identified, developed through maturation programs, and transferred. Key programs include Booster Innovation Montpellier (BIM) and the Programme d'Excellence de l'ISITE (PEI).
• CNRS (Centre National de la Recherche Scientifique)coreStrategic or Co-development PartnerMajor research partner whose laboratories generate technologies transferred by AxLR. CNRS Innovation participated alongside AxLR at the Quantum Zone at VivaTech 2026 as part of the QuantXium consortium.
• CNRS InnovationcoreStrategic or Co-development PartnerCNRS Innovation co-exhibited with AxLR at VivaTech 2026 Quantum Zone, representing the national quantum technology ecosystem including QuantXium program, PEPR Quantique, and Q-Loop.
• PUI de Montpellier (Pôle Universitaire d'Innovation)coreStrategic or Co-development PartnerAxLR collaborates with PUI de Montpellier on the Booster Innovation Montpellier (BIM) program and the Companies and Campus initiative. PUI hosts and co-organizes events including material recycling meetings and Biorézo Montpellier.
• TTM FactorycoreImplementation/ SI/ Consulting PartnerAxLR's startup incubator program (TTM Factory) supports emerging deeptech companies through the critical phase between research and market readiness. Used for startups including Graft Smart (incubated since 2024) and E-ETHYLENE.
• Région Occitanie / Pyrénées-MéditerranéemajorStrategic or Co-development PartnerRegional government authority and AxLR shareholder. Co-funded the third tranche of AxLR financing (€22M for 2019-2021). Co-exhibited with AxLR at VivaTech 2026 and supports programs including the Booster Innovation Montpellier and Maison du Quantique Occitanie.
• Institut Carnot Chimie Balard CirimatcoreStrategic or Co-development PartnerCarnot Institute co-organizing the 'Rencontres autour du recyclage des matériaux' (May 2026) with PUI de Montpellier and AxLR, focused on metal and composite recycling technologies.
• Institut Pasteur de Tunis (IPT)minorStrategic or Co-development PartnerInternational research partner in a tripartite agreement with IRD and AxLR (signed December 2018 in Tunis), supporting the maturation and valorization of a leishmaniasis vaccine project. First AxLR partnership with IPT.
• IRD (Institut de Recherche pour le Développement)minorStrategic or Co-development PartnerIRD partnered with AxLR and Institut Pasteur de Tunis on a leishmaniasis vaccine project (€179K, 14-month project). IRD conducts development work in its facilities in Tunis and Montpellier.
• Institut Européen des Membranes (IEM)coreStrategic or Co-development PartnerResearch institute (UM/CNRS/ENSCM) whose researchers developed key technologies transferred by AxLR, including E-ETHYLENE's CO₂-to-ethylene conversion (Damien Voiry) and NovaSorb's PFAS capture materials (Mona Semsarilar).
• Institut de Génomique Fonctionnelle (IGF)coreStrategic or Co-development PartnerResearch institute (UM/CNRS) where Philippe Rondard (Inserm) and Jean-Philippe Pin (CNRS) developed llama nanobody technology for schizophrenia treatment, supported by AxLR since 2019 (€317K investment).
• Institut des Biomolécules Max Mousseron (IBMM)minorStrategic or Co-development PartnerResearch institute (UM/CNRS/ENSCM) where Xavier Garric leads the PEASY project for male urinary incontinence medical device. Project is undergoing real-world testing and clinical study at CHU de Nîmes.
• Institute for Regenerative Medicine & Biotherapy (IRMB)minorStrategic or Co-development PartnerResearch institute whose scientists developed the protein clock technology for biological age estimation of skin, transferred to Skinomix.ai via exclusive license agreement with AxLR.
• Graft SmartcoreStrategic or Co-development PartnerStartup (incorporated December 2023, CEO Arnaud Cluzel) commercializing the Flow Graft connected organ transplantation platform. Supported by AxLR since 2021 with >€1M investment, incubated by TTM Factory. Software commercialization planned for 2026.
• E-ETHYLENEcoreStrategic or Co-development PartnerStartup (co-founded by Damien Voiry as CSO and Alfonso Morriello as CEO) commercializing CO₂-to-ethylene electrochemical conversion technology. Licensed exclusively worldwide in July 2023. Supported by AxLR since 2020 (€670K investment), incubated by TTM Factory. Partner of European RESET-CO₂ project.
• Nervosave TherapeuticscoreStrategic or Co-development PartnerBiotech startup (SAS, Montpellier) developing gene therapy for Charcot-Marie-Tooth disease type 1A (CMT1A). Spun off from INSERM, supported by AxLR, Région Occitanie, and BIC Montpellier. CEO Nicolas Tricaud. AxLR strengthened strategic partnership in November 2025.
• KondreecoreStrategic or Co-development PartnerStartup developing an antioxidant therapy for facioscapulohumeral muscular dystrophy (FSH myopathy). Announced a world-first clinically validated therapy breakthrough in March 2026, partnered with AxLR, Université de Montpellier, and CHU de Montpellier.
• Skinomix.aiminorStrategic or Co-development PartnerStartup (created 2025, CEO Marc Bessoles) commercializing a protein clock technology from IRMB for evaluating biological age of skin. AxLR transferred an exclusive worldwide license for the technology in May 2026.
• APE EditionsminorImplementation/ SI/ Consulting PartnerWebsite development and maintenance partner for AxLR's digital presence. Located at 4 rue de la salle l'Evêque, 34000 Montpellier (RCS 383 010 030 00021).
• EurobiomedminorStrategic or Co-development PartnerHealthcare and biotech cluster co-organizing Biorézo Montpellier (April 2026) with AxLR, featuring pitches from Ventuno Biotech, SoteriaBio, SITERA Pharma, and Worldwide Clinical Trials.
• GRDFminorStrategic or Co-development PartnerFrench gas distribution operator that awarded E-ETHYLENE a European call-for-projects grant for its role in valorizing biogenic CO₂ from methanization, supporting decarbonization of gas networks.
• MedValléeminorStrategic or Co-development PartnerRegional initiative (Boost Invest program) supporting companies with high potential in fundraising. E-ETHYLENE joined the program to accelerate its funding round.
• RESET-CO₂ consortiumminorStrategic or Co-development PartnerEuropean project accelerating electrochemical conversion of CO₂ to renewable ethylene, in which E-ETHYLENE is a partner alongside Voltachem (TNO), Johnson Matthey, and other industrial actors.
• BXVenturesminorStrategic or Co-development PartnerEuropean ClimateTech startup studio co-founding and financing startups including the future NovaSorb company, which is developing PFAS capture materials from research at Institut Européen des Membranes.
• Consortium QuantXiumcoreStrategic or Co-development PartnerNational program dedicated to acceleration and structuring of quantum innovation in France, part of France 2030 Strategy. AxLR participated in the Quantum Zone at VivaTech 2026 alongside CNRS Innovation, presenting the QuantXium program to ministers and CNRS leadership.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• SATT Paris-Saclay: SATT Paris-Saclay is another French Société d'Accélération du Transfert de Technologie operating under the same government-mandated model, performing technology maturation, IP protection, and licensing between public research labs and industry in the Paris-Saclay cluster. Direct structural peer with identical mandate and funding mechanism.
• Linksium (SATT Grenoble Alpes): Linksium is the SATT for the Grenoble-Alpes region, performing the same technology transfer acceleration role for public research labs (CEA, Université Grenoble Alpes) as AxLR does for Occitanie Méditerranée. Direct peer under identical national SATT network framework.
• SATT Sud-Est: SATT Sud-Est covers the PACA and Corsica regions under the same national SATT framework, providing technology maturation and transfer services from public research to industry. Sister SATT organization with overlapping service offerings and customer segments.
• Inserm Transfert: Inserm Transfert is the technology transfer office for France's national institute of health and medical research. While focused exclusively on biomedical research (one of AxLR's five domains), it performs the same maturation, IP, and licensing function and is a frequent co-investor in health-tech spinoffs with AxLR.
• INRAE Transfert: INRAE Transfert handles technology transfer for France's national agronomy and environment research institute. Directly comparable as a French public-research TTO active in one of AxLR's core domains (Agronomy, Ecology, Environment).

Broad incumbents

• CNRS Innovation: CNRS Innovation is the dedicated technology transfer subsidiary of France's largest public research organization. It is both a partner and adjacent player to AxLR, with broader national scope and deeper CNRS lab relationships across all disciplines AxLR covers.
• Oxford University Innovation: Oxford University Innovation is the technology transfer arm of the University of Oxford, performing maturation, IP, and licensing for one of Europe's most research-intensive universities. Comparable as an established European university TTO with deeper commercialization infrastructure.
• Cambridge Enterprise: Cambridge Enterprise handles technology transfer and startup creation for the University of Cambridge. Comparable as a mature European university TTO with extensive spinoff creation track record in life sciences and deeptech.
• Max Planck Innovation: Max Planck Innovation is the technology transfer office of the Max Planck Society in Germany, handling IP and commercialization for basic research. Comparable as a European public-research TTO operating across multiple scientific domains.

Others

• Bpifrance: Bpifrance is France's public investment bank that co-funds SATTs (including AxLR's €22M tranche) and provides downstream funding to SATT-supported startups through programs like French Tech Seed and BFT Lab. Adjacent ecosystem participant and key financial partner rather than direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/satt-axlr
• Xx.com/sattaxlr

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AxLR